Back

Prescription of beta blockers at lower dose is associated with poor outcomes in heart failure patients with central sympathetic overactivation

28 August 2016 (17:40 - 17:50)
Organised by:
Congress Presentation Part of: Neuro-hormonal activation: target in HF Neurohormones ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Takashi Akabane

University of Toyama, Toyama (Japan)

8 More presentations in this session

Presentation thumbnail
Novel insights into the role of insulin-like growth factor 1 in the regulation of myocardial redox state in humans
Doctor I. Akoumianakis (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Neprilysin and type c natriuretic peptide receptor - new interesting targets for heart failure therapy
Doctor K. Kodziszewska (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Preserved and maximal O2 extraction during exercise in heart failure patients with chronotropic insufficiency: evidence for a central cardiac rather than peripheral role in limiting oxygen uptake
Doctor G. Generati (Lodi, IT)
Abstract Slides Video
Presentation thumbnail
Refining vagus nerve stimulation in heart failure: Selective optogenetic recruitment of c-fibre vagal efferents is sufficient to preserve left ventricular function in a rat model
Doctor A. Machhada (London, GB)
Abstract Slides Video
Presentation thumbnail
Effects of neurohormonal stimulation on cardiomyocyte telomere length and effects on cellular function
Doctor M. Brandt (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Neuro-hormonal activation: target in HF

The Event

Event poster

ESC Congress 2016

28 August 2016 17:40 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources